CMS Changes for 2026: What Medical Coders Need to Know
As healthcare policy continues to evolve, the Centers for Medicare & Medicaid Services (CMS) has finalized significant regulatory and coding updates for Calendar Year (CY) 2026. Medical coding CMS changes for 2026 affect the Medicare Physician Fee Schedule (MPFS), CPT/HCPCS codes, documentation requirements, reimbursements, and other Medicare Part B and outpatient payment policies. Many provisions go into effect January 1, 2026. Federal Register
Major Payment Policy Shifts in the 2026 Medicare Physician Fee Schedule
Conversion Factor Changes
One of the most consequential changes is the update to the Medicare physician fee schedule conversion factor (CF):
- CMS finalized a base CF of about $33.40 for most clinicians.
- A slightly higher CF of $33.57 applies to clinicians participating in qualifying alternative payment models (APMs).
This represents a notable increase compared to 2025, while incorporating statutory adjustments from Congress and a productivity/efficiency adjustment.
Specialty vs. Primary Care Payment
- While primary care and certain independent practices see relative gains under the new schedule, many facility-based and specialist services experience payment reductions due to efficiency adjustments and site-of-service valuation differences.
CPT/HCPCS Code Changes for 2026
Annual CPT/HCPCS Update
CMS annually aligns Medicare coding with the latest AMA CPT codes and HCPCS Level II updates. For 2026:
- 288 CPT codes are newly added or revised, with deletions and editorial changes across multiple specialties.
- The Physician Self-Referral Code List has been updated to reflect new and deleted CPT/HCPCS codes for compliance with Stark Law reporting. Centers for Medicare & Medicaid Services
These changes carry direct billing and compliance implications, particularly for labs, imaging, therapy services, and emerging technologies.
Documentation & Coding Rule Refinements
E/M Coding and Documentation
CMS has refined some E/M coding guidelines to emphasize greater specificity and documentation integrity:
- Clearer definitions for medical decision-making levels.
- Tighter review and validation of time-based billing, especially for prolonged services.
Accurate documentation is now more critical than ever for defending code assignments against audits and ensuring appropriate reimbursement.
Medicare Part B and Ancillary Billing Updates
Average Sales Price (ASP) Policies
CMS finalized changes to how ASP is calculated for Part B drugs, ensuring that units sold at the maximum fair price are included in ASP calculations beginning in 2026. This affects reimbursement levels for infused or injectable medications.
340B and Part D Rebate Rules
CMS has finalized a claims-based method for excluding 340B units from Part D rebate calculations, establishing a data repository for Part D claims with dates of service in 2026 and beyond.
RHC & FQHC Coding
Rural Health Clinics (RHCs) and Federally Qualified Health Centers (FQHCs) must report individual component CPT codes for Collaborative Care Model and Communications Technology-Based Services instead of bundled codes for separate payment.
OPPS & ASC Payment Policy Developments
Though separate from physician fee schedule changes, coders working in hospital outpatient departments (OPPS) and ambulatory surgical centers (ASC) must be aware of:
- 2.6% increase to OPPS payment rates for 2026 after productivity adjustments.
- Continued phase-out of the inpatient-only (IPO) list and expansion of site-neutral payment policies.
- A 0.5% reduction in the OPPS conversion factor to correct past 340B overpayments.
Compliance, Audits & Risk Management
CMS is increasingly focusing on documentation integrity and compliance risk:
- Enhanced edits and monitoring for overlapping services.
- Tightening of rule interpretations to prevent overpayments and erroneous billing.
Coders should audit internally for:
- Proper E/M level support.
- Correct bundling and unbundling.
- Appropriate modifiers and time-based billing justification.
Medicare Advantage, Part D, and Other CMS Policy Changes for 2026
Here’s a detailed overview of the finalized CMS Top Changes for 2026, including policy and payment changes affecting Medicare Advantage (MA), Part D, traditional Medicare, and ACA Marketplace plans:
Medicare Advantage (Part C)
- In the final CY 2026 Rate Announcement, CMS is increasing payments to MA plans by an average of 5.06% over 2025, higher than the initial 4.33% projection in the Advance Notice. These increased payments represent over $25 billion in additional funding for MA contractors
- Key drivers include a rise in the effective growth rate and adjustments in the risk scoring model and normalization
- CMS finalized more detailed prior authorization guardrails to limit burdensome utilization management by MA plans, along with new restrictions on non‑health-related Special Supplemental Benefits for the Chronically Ill (SSBCI), including bans on coverage for non‑healthy food items
Medicare Part D
Part D Redesign & IRA Implementation
- CMS issued the Final CY 2026 Part D Redesign Program Instructions (dated April 7, 2025), providing guidance on IRA-implemented changes, including the Medicare Drug Price Negotiation Program (MFPs) and formulary inclusion requirements for selected drugs
-
Under the Part D redesign for 2026:
- The out-of-pocket (OOP) threshold rises to $2,100 (up from $2,000 in 2025), indexed for inflation
- The insured remains responsible for 25% coinsurance during the initial coverage phase; CMS and manufacturers cover the balance, with CMS taking responsibility for a 10% subsidy on selected drugs during price applicability periods
- In the catastrophic phase, cost-sharing drops to zero, and CMS provides 40% reinsurance for selected drugs during pricing periods
Codified IRA-Based Benefits
- No deductible and zero cost-sharing now apply permanently for Part D-covered adult vaccines recommended by ACIP, as well as covered insulin products—consistent with IRA mandates
- CMS also codified rules for the Medicare Prescription Payment Plan (MPPP): starting 2026, beneficiaries are automatically re-enrolled each year unless they opt out, helping spread drug costs over time
What Didn’t Make It
- CMS formally declined to finalize proposals allowing Part D/ D/Medicaid coverage of anti-obesity medications (AOMs) like GLP-1 agents for chronic weight management, overturning prior regulatory reinterpretations
- Proposed AI regulations and enhanced health equity analyses regarding utilization management were also not finalized, though CMS may revisit these in future rulemaking
Traditional Fee-for-Service Medicare
While MA and Part D dominate the headlines, the CMS final rule also extended updates to traditional Medicare, particularly:
- New prior authorization programs in six states—New Jersey, Ohio, Oklahoma, Texas, Arizona, and Washington—using the WISeR AI-assisted review system to reduce unnecessary services and improve efficiency
ACA Marketplace Plans
Although CMS’s April 2025 final rule focuses primarily on Medicare programs, many Part D and MA policies—vaccine and insulin cost-sharing, and negotiated drug price implementations—could also indirectly influence ACA Marketplace plans, especially those offering Part D-equivalent coverage or aligned cost-sharing features. However, explicit 2026 Marketplace plan policy guidance is not outlined in this rule.
Summary Table: Key Policies Finalized for 2026
| Program | Major Finalized Changes |
|---|---|
| Medicare Advantage (MA) | +5.06% payment increase; stronger prior authorization guardrails; SSBCI benefit restrictions |
| Medicare Part D | OOP cap raised to $2,100; cost-sharing caps on insulin & vaccines continue; MPPP auto‑renewal; IRA drug negotiation provisions in effect |
| Traditional Medicare | AI-supported prior auth pilot across six states via WISeR system |
| ACA Marketplace | No direct rule changes, but spill‑over effects from Part D and drug pricing reforms are likely |
Why It Matters
- Beneficiaries may see lower drug costs, improved predictability, and enhanced protections starting in 2026—especially for insulin and vaccines.
- Health plans (MA and Part D sponsors) will receive higher payments but also face stricter oversight around prior authorization and supplemental benefits.
- Although there’s no Medicare coverage for obesity drugs, cost-sharing improvements reflect the CMS commitment to IRA-based reforms.
Final Tips for Coders & Billers in 2026
Prepare Your Practice
- Update internal coding manuals with the 2026 CPT/HCPCS sets.
- Conduct staff training on documentation changes and E/M refinements.
Review Payer Policies
- Verify Medicare Administrative Contractor (MAC) guidance for local coverage differences.
- Reconfirm proper claim submission for services impacted by site-neutral and bundled payment shifts.
Track Regulatory Updates
- Follow CMS flash reports and Federal Register notices for late-breaking changes that may occur throughout 2026.
CMS’s 2026 updates bring sweeping impacts across:
- Medicare physician payment rates and conversion factors.
- New, deleted, and revised CPT/HCPCS codes aligned with practice evolution.
- Documentation emphasis, audit vulnerability, and compliance risk.
- Part B reimbursement policies and drug pricing methodology.
- OPPS and ASC payment methodologies.
Proactive training, strong documentation practices, and up-to-date policy knowledge will be essential for accurate coding and optimized reimbursement in 2026 and beyond.
